Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1

Conditions

Multiple Myeloma 3Recurrence 1Neoplasms, Plasma Cell 1Myelodysplastic Syndromes 1Motor Activity 1Leukemia, Myeloid, Acute 1Leukemia 1Hematologic Diseases 1Graft vs Host Disease 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 15Antilymphocyte Serum 11fludarabine phosphate 10Cyclosporine 9Busulfan 9Peripheral Blood Stem Cell Transplantation 8Mycophenolic Acid 7Filgrastim 7Methotrexate 6Whole-Body Irradiation 5Melphalan 5fludarabine 4Radiotherapy 4Methylprednisolone 4Cord Blood Stem Cell Transplantation 4Tacrolimus 3Psychiatric Rehabilitation 3Palliative Care 3Blood Specimen Collection 3sargramostim 2Thiotepa 2Therapeutics 2Stem Cell Transplantation 2Polymerase Chain Reaction 2Injections 2Granulocyte Colony-Stimulating Factor 2Dexamethasone 2Cytarabine 2Behavior Therapy 2Ascorbic Acid 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Myelodysplastic Syndromes × Thalidomide × Clear all
NCT00023530 2016-02-18

Blood and Marrow Transplant Clinical Research Network

National Heart, Lung, and Blood Institute (NHLBI)

Phase NA Completed
MyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hematologic Diseases, Leukemia, Multiple Myeloma, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡